CEO Forum: IPO and Growth

Mercia’s CEO Forum event on the topic of IPO and growth was held at its Manchester office and was hosted by Dr Alistair Forbes, Investment Director and Head of Mercia’s Software and the Internet sector. Speakers shared their extensive experience with a group of CEOs from Mercia’s investment portfolio in a lively and interactive session.

New Direct Investment into W2 Global Data Solutions

Mercia Technologies PLC is pleased to announce a new direct investment into W2 Global Data Solutions Limited (W2). Mercia’s £2.0million investment is part of a £3.0million funding round alongside the Development Bank of Wales. Mercia now has a direct equity holding of 17.4% in W2 and this direct investment follows on from initial funding rounds

Dialysis pioneer Invizius named ‘Best Innovative MedTech’

Invizius, a University of Edinburgh spinout whose technology promises to improve the lives of millions of dialysis patients, has been named Best Innovative MedTech company at the prestigious OBN Awards. The company’s success in the awards, which have a high profile in the life sciences sector, follows on from a seed investment of £500,000 from

Universities are leading the way

UK universities are world renowned and Mercia, which was has a network of 19 university partners, was recently identified as one of the most active investors in UK university spinouts* having completed 23 investments in 2017. Our network of partners receives £1.8billion in R&D funding which is actually larger than OxBridge at £1.3billion. The University

New Emerging Star investment into Locate Bio

Mercia Technologies PLC is pleased to announce a new direct investment of £0.5million into Locate Bio Limited (Locate). Locate is a specialist regenerative medicine and medical device company based in Nottingham. As one of the leaders in its field, the Locate team has been working for over a decade on developing a novel drug delivery